The joint effort will focus on providing patients with medication guidance, reminders, tracking of efficacy and health education.

Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...

GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...

Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum of ...

Rhythm Pharmaceuticals develops medicines for rare disorders that cause weight gain. The company's only approved product is ...

In what Science magazine has dubbed “Novo Nordisk’s Canadian Mistake,” Ozempic is soon to come off patent in Canada, opening ...

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

Fangzhou & Novo Nordisk sign MoU to establish a new ecosystem for health management: Beijing Monday, July 21, 2025, 17:00 Hrs [IST] Fangzhou Inc., a leader in Internet healthcare ...

GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity ...

The B.C. government is restricting the sales of two more diabetes drugs to people outside Canada amid rising demand for the ...

You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by ...